4/16
06:48 pm
lyel
Lyell Immunopharma: Testing The T-Cell Thesis With 2 Upcoming Data Catalysts [Seeking Alpha]
Medium
Report
Lyell Immunopharma: Testing The T-Cell Thesis With 2 Upcoming Data Catalysts [Seeking Alpha]
4/4
07:19 am
lyel
Outpace Bio Announces Multiple Presentations at the 2024 American Association of Cancer Research (AACR) Annual Meeting [Yahoo! Finance]
Low
Report
Outpace Bio Announces Multiple Presentations at the 2024 American Association of Cancer Research (AACR) Annual Meeting [Yahoo! Finance]
3/20
05:20 pm
lyel
2seventy bio appoints Eli Casdin and Charles Newton to its board of directors [Seeking Alpha]
Low
Report
2seventy bio appoints Eli Casdin and Charles Newton to its board of directors [Seeking Alpha]
3/19
10:18 am
lyel
CHARM Therapeutics Announces Foundation of Scientific Advisory Board (SAB) [Yahoo! Finance]
Medium
Report
CHARM Therapeutics Announces Foundation of Scientific Advisory Board (SAB) [Yahoo! Finance]
3/17
10:13 am
lyel
Lyell Immunopharma, Inc.'s (NASDAQ:LYEL) market cap decline of US$89m may not have as much of an impact on institutional owners after a year of 1.4% returns [Yahoo! Finance]
Medium
Report
Lyell Immunopharma, Inc.'s (NASDAQ:LYEL) market cap decline of US$89m may not have as much of an impact on institutional owners after a year of 1.4% returns [Yahoo! Finance]
3/7
01:53 pm
lyel
Lyell Immunopharma (LYEL) Is Up 28.45% in One Week: What You Should Know [Yahoo! Finance]
Low
Report
Lyell Immunopharma (LYEL) Is Up 28.45% in One Week: What You Should Know [Yahoo! Finance]
3/5
04:43 pm
lyel
Lyell Immunopharma Announces the Acceptance of Three Abstracts for Presentation at 2024 AACR Annual Meeting [Yahoo! Finance]
Medium
Report
Lyell Immunopharma Announces the Acceptance of Three Abstracts for Presentation at 2024 AACR Annual Meeting [Yahoo! Finance]
3/5
04:30 pm
lyel
Lyell Immunopharma Announces the Acceptance of Three Abstracts for Presentation at 2024 AACR Annual Meeting
Medium
Report
Lyell Immunopharma Announces the Acceptance of Three Abstracts for Presentation at 2024 AACR Annual Meeting
2/29
03:42 pm
lyel
Lyell Immunopharma, Inc. (NASDAQ: LYEL) had its price target lowered by analysts at HC Wainwright from $8.00 to $6.00. They now have a "buy" rating on the stock.
Low
Report
Lyell Immunopharma, Inc. (NASDAQ: LYEL) had its price target lowered by analysts at HC Wainwright from $8.00 to $6.00. They now have a "buy" rating on the stock.
2/28
04:53 pm
lyel
Lyell Immunopharma Inc (LYEL) Reports 2023 Financial Results and Business Highlights [Yahoo! Finance]
Low
Report
Lyell Immunopharma Inc (LYEL) Reports 2023 Financial Results and Business Highlights [Yahoo! Finance]
2/28
04:13 pm
lyel
Lyell Immunopharma Reports Business Highlights and Financial Results for the Fourth Quarter and Full Year 2023 [Yahoo! Finance]
Low
Report
Lyell Immunopharma Reports Business Highlights and Financial Results for the Fourth Quarter and Full Year 2023 [Yahoo! Finance]
2/28
04:05 pm
lyel
Lyell Immunopharma Reports Business Highlights and Financial Results for the Fourth Quarter and Full Year 2023
Low
Report
Lyell Immunopharma Reports Business Highlights and Financial Results for the Fourth Quarter and Full Year 2023
2/26
04:05 pm
lyel
Lyell Immunopharma Announces Participation in March Investor Conferences
Medium
Report
Lyell Immunopharma Announces Participation in March Investor Conferences